# Oramed Pharmaceuticals Inc.: Form 8-K, filed Mar 31, 2026

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2026-03-31
- Accepted by EDGAR: Mar 31, 2026, 20:20 ET
- Period: 2026-03-25
- Accession: 0001213900-26-037474
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390026037474/ea0284244-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390026037474/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390026037474/ea0284244-8k_oramed.htm

Filed Mar 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-037474. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.